Abstract:Herein we describe the synthesis of a series of new potent tachykinin NK(2) receptor antagonists by the modulation of the C- and N-terminal moieties of ibodutant (MEN 15596, 1). The N-terminal benzo[b]thiophene ring was replaced by different substituted naphthalenes and benzofurans, while further modifications were evaluated at the C-terminal tetrahydropyran moiety. Most compounds demonstrated a high affinity for the human NK(2) receptor and high in vitro antagonist potency, indicating that a wide range of sub… Show more
The benzo[b]thiophene nucleus and the acylhydrazone functional group were combined to prepare three new series of compounds for screening against Staphylococcus aureus. The reaction of substituted benzo[b]thiophene-2-carboxylic hydrazide and various aromatic or heteroaromatic aldehydes led to a collection of 26 final products with extensive structural diversification on the aromatic ring and on position 6 of the benzo[b]thiophene nucleus. The screening lead to the identification of eight hits, including (E)-6-chloro-N’-(pyridin-2-ylmethylene)benzo[b]thiophene-2-carbohydrazide (II.b), a non-cytotoxic derivative showing a minimal inhibitory concentration of 4 µg/mL on three S. aureus strains, among which were a reference classical strain and two clinically isolated strains resistant to methicillin and daptomycin, respectively.
The benzo[b]thiophene nucleus and the acylhydrazone functional group were combined to prepare three new series of compounds for screening against Staphylococcus aureus. The reaction of substituted benzo[b]thiophene-2-carboxylic hydrazide and various aromatic or heteroaromatic aldehydes led to a collection of 26 final products with extensive structural diversification on the aromatic ring and on position 6 of the benzo[b]thiophene nucleus. The screening lead to the identification of eight hits, including (E)-6-chloro-N’-(pyridin-2-ylmethylene)benzo[b]thiophene-2-carbohydrazide (II.b), a non-cytotoxic derivative showing a minimal inhibitory concentration of 4 µg/mL on three S. aureus strains, among which were a reference classical strain and two clinically isolated strains resistant to methicillin and daptomycin, respectively.
“…The synthesis of NanoGoblin ( 6 ) began with the construction of a 1,3-dioxane head unit through the acetalization of triol 7 with methylal (Scheme 2). 25 The resulting alcohol 8 was then converted to iodide 9 , and the subsequent treatment of 9 with CF 3 SO 2 Na in toluene at 100 °C in the presence of 15-crown-5 afforded trifluoromethyl sulfone 10 . Higher reaction temperatures and the replacement of toluene with dimethylformamide (DMF) decreased the yield of 10 .…”
Small,
“doll”-shaped tetracyanocyclopentadienide
bearing a 1,3-dioxane acetal “head” and cyano “hands”
and “feet” was synthesized. Its pyridinium salt, which
was named NanoGoblin, exhibited catalytic activity in the methanolysis
of acetals, as demonstrated by the reaction with NanoKid in methanol-
d
4
, where the acetal head of NanoKid was converted
to a deuterated dimethyl acetal moiety.
“…of 4‐methoxybenzyl chloride [44,45] . A Rap‐Stoermer cyclisation of the mono PMB‐protected aldehyde 20 with ethyl bromoacetate afforded benzofuranoic acid 21 in up to 86 % yield [46] . Subsequent coupling of N,O‐dimethyl hydroxylamine with EDCI generated the Weinreb amide 22 in sufficient yield for further coupling with lithium benzimidazolide to provide a tautomeric mixture of ketones 23 and 24 in a yield of 76 %.…”
Ras proteins are implicated in some of the most common life‐threatening cancers. Despite intense research during the past three decades, progress towards small‐molecule inhibitors of mutant Ras proteins still has been limited. Only recently has significant progress been made, in particular with ligands for binding sites located in the switch II and between the switch I and switch II region of K‐Ras4B. However, the structural diversity of inhibitors identified for those sites to date is narrow. Herein, we show that hydrazones and oxime ethers of specific bis(het)aryl ketones represent structurally variable chemotypes for new GDP/GTP‐exchange inhibitors with significant cellular activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.